Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Engineering apoptosis

Cell death plays a role in many human diseases, and protein-protein interactions are the vessel through which most cellular signaling is transduced. Two groups of academic researchers now have addressed both issues, developing compounds that promote cell death by regulating protein-protein interactions.

The Bcl-2 family of proteins is composed of both pro- and anti-apoptotic proteins and as such has long been of therapeutic interest. All Bcl-2 family

Read the full 660 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE